Cheapest Sermorelin Providers in 2026 — Ranked & Reviewed
Sermorelin costs vary widely between telehealth clinics, and most quote your price after the consultation rather than advertising it up front. The providers below are ranked on value — how fairly and transparently each clinic prices its programs — so the ones least likely to surprise you at checkout come first. Sermorelin is prescription-only in the US, so every clinic here prescribes through a licensed provider rather than selling grey-market "research peptides" with no prescriber involved.
95 providers compared
New to Cheapest Sermorelin? Read our full Cheapest Sermorelin guide — evidence, dosing, safety and side effects.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
95 cheapest sermorelin providers compared · independently scored against our six-factor methodology.
Compare the top providers at a glance
Logos, our editorial rating, price, medications, and coverage — the fastest way to narrow the list.
- ★ Editor's Pick
Lowest per-vial GLP-1 cost: compounded sema $25, tirz $45, $39 telehealth Rx, no subscription, 28 states
From /moCheck pricingCoverage28 statesMedicationsBPC-157CJC-1295 / IpamorelinGHK-CuGlutathioneGonadorelinIpamorelinNAD+PT-141SermorelinTB-500Tesamorelin - Nationwide Coverage
mainstream telehealth GLP-1 access
From /moCheck pricingFlat at every doseCoverage50 statesMedicationsGlutathioneNAD+Sermorelin - Best Budget
budget-conscious shoppers
From /moCheck pricingCoverageCheck intakeMedicationsNAD+Sermorelin compounded semaglutide and tirzepatide at a flat monthly price
From /moCheck pricingFlat at every doseCoverageCheck intakeMedicationsGlutathioneNAD+Sermorelinbest overall value
From /moCheck pricingFlat at every doseCoverage50 statesMedicationsNAD+Sermorelinlow flat-rate compounded GLP-1 pricing at every dose
From /moCheck pricingCoverage50 statesMedicationsGlutathioneNAD+Sermorelin- Transparent Pricing
Low-cost compounded semaglutide or tirzepatide nationwide with no membership and everything included
From /moCheck pricingCoverage50 statesMedicationsGlutathioneNAD+Sermorelin men seeking flat-priced compounded GLP-1 access alongside TRT or peptide therapy
From /moCheck pricingCoverage42 statesMedicationsNAD+Sermorelin
| Provider | Rating | From /mo | Medications | Coverage | |
|---|---|---|---|---|---|
| ★ Editor's Pick Lowest per-vial GLP-1 cost: compounded sema $25, tirz $45, $39 telehealth Rx, no subscription, 28 states | Check pricing | BPC-157CJC-1295 / IpamorelinGHK-CuGlutathioneGonadorelinIpamorelinNAD+PT-141SermorelinTB-500Tesamorelin | 28 states | Visit → | |
| Nationwide Coverage mainstream telehealth GLP-1 access | Check pricing Flat pricing | GlutathioneNAD+Sermorelin | 50 states | Visit → | |
| Best Budget budget-conscious shoppers | Check pricing | NAD+Sermorelin | Check intake | Visit → | |
compounded semaglutide and tirzepatide at a flat monthly price | Check pricing Flat pricing | GlutathioneNAD+Sermorelin | Check intake | Visit → | |
best overall value | Check pricing Flat pricing | NAD+Sermorelin | 50 states | Visit → | |
low flat-rate compounded GLP-1 pricing at every dose | Check pricing | GlutathioneNAD+Sermorelin | 50 states | Visit → | |
| Transparent Pricing Low-cost compounded semaglutide or tirzepatide nationwide with no membership and everything included | Check pricing | GlutathioneNAD+Sermorelin | 50 states | Visit → | |
men seeking flat-priced compounded GLP-1 access alongside TRT or peptide therapy | Check pricing | NAD+Sermorelin | 42 states | Visit → |
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
Detailed Reviews
A note on prices below: any dollar figure in these provider summaries refers to that clinic’s GLP‑1 weight-loss program, not to Cheapest Sermorelin. Peptide pricing is rarely published up front — check the provider’s own site for current cost.
RxPepsDirect
Best for: Lowest per-vial GLP-1 cost: compounded sema $25, tirz $45, $39 telehealth Rx, no subscription, 28 states
RxPepsDirect (Peptide RX LLC) is a per-vial compounded GLP-1 telehealth platform offering semaglutide/B12 from $25/vial and tirzepatide/B12 from $45/vial, dispensed through Optimal Balance Pharmacy (503A, Texas) after a $39 asynchronous online medical visit. Licensed NP/PA prescribers supervised by Medical Director Dr. Jonathan Snipes, MD issue patient-specific compounded Rx under the 503A pathway with no subscription required. FedEx overnight delivery, syringes, and travel case included; available in 28 states and DC.
Score Breakdown
Pros
- ✓Industry-lowest GLP-1 pricing: compounded semaglutide from $25/vial, tirzepatide from $45/vial — no subscription or recurring commitment required
- ✓Real 503A telehealth Rx: licensed NP/PA prescribers + MD medical director (Dr. Jonathan Snipes, NPI 1821250077); patient-specific Rx dispensed by
- ✓FedEx overnight shipping at $15 flat; ships pre-reconstituted and includes syringes, alcohol wipes, and reusable cooled travel case
- ✓Independent batch COA testing by Eagle Analytical (FDA-registered, A2LA ISO 17025): 54/54 sterility and endotoxin passes published publicly on
- ✓No subscription required; $39 flat visit fee covers up to 3 peptides per Rx; pay per vial with no ongoing commitment
Cons
- ✗No LegitScript certification; company founded 2026 — no public track record or long-term patient-outcomes data
- ✗Minimal clinical oversight: $39 asynchronous intake form only — no live video consult required, no labs mandated, no monitoring protocol; lowest
- ✗Per-vial pricing makes true monthly cost opaque; every refill costs another $39 visit fee on top of vial price and $15 shipping
- ✗Only 28 states + DC; excludes California, most of the Southeast (AL, AR, GA, MS, NC, SC, TN, VA), and parts of Midwest
- ✗No coaching, labs, dietitian support, or clinical monitoring included at any tier — purely prescription + dispensing
bmiMD
Verified partnerBest for: mainstream telehealth GLP-1 access
Medical weight loss clinic offering GLP-1 prescriptions through telehealth.
Score Breakdown
Pros
- ✓Both semaglutide and tirzepatide available
Cons
- ✗Pricing not publicly disclosed
Ivim Health
Best for: budget-conscious shoppers
Telehealth weight loss program with low entry-tier semaglutide pricing and a separate program fee for tirzepatide.
Score Breakdown
Pros
- ✓Aggressively low monthly pricing
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
Cons
- ✗Limited public information on program details
Oak
Verified partnerBest for: compounded semaglutide and tirzepatide at a flat monthly price
Telehealth provider offering compounded GLP-1 medications (semaglutide and tirzepatide) operated by Oak Longevity Holdings Corp. with prescriptions issued through NVP Medical Group, P.A.
Score Breakdown
Pros
- ✓Both compounded semaglutide ($119/mo) and tirzepatide ($185/mo) on a single platform
- ✓$200-off new-patient offer advertised — final discounted price is shown after the intake quiz
- ✓LegitScript-certified pharmacy network
- ✓No video call required for initial approval; flat per-month pricing across all dose strengths
Cons
- ✗Pharmacy partners are not publicly named on the marketing site (material gap for YMYL disclosure)
- ✗Operates in 45 states per Terms of Use, but the public state list is gated behind the signup intake
- ✗No brand-name Wegovy / Zepbound / Mounjaro / Ozempic available — compounded only
- ✗Fees are non-refundable per Terms of Use; binding arbitration under Delaware law
CoreAge Rx
Best for: best overall value
CoreAge Rx offers LegitScript-verified compounded semaglutide and tirzepatide with free 2-day shipping to all 50 states. Backed by licensed physicians and 24/7 support, it delivers the most competitive pricing in the compounded GLP-1 space.
Score Breakdown
Pros
- ✓LegitScript certified — rigorous pharmacy standards
- ✓Free 2-day shipping nationwide
- ✓Both semaglutide and tirzepatide available
- ✓Lowest per-month pricing in the compounded segment
- ✓24/7 support team
- ✓All 50 states covered
Cons
- ✗Compounded only — no brand-name Ozempic or Wegovy
- ✗Newer brand with fewer independent reviews than legacy players
How we rank & what counts as “legit”
Every provider in this ranking is scored against our published six-factor rubric[1] — value, effectiveness, user experience, trust & safety, accessibility, and support.
Brand-name Wegovy, Zepbound, Ozempic, and Mounjaro are separately FDA-approved under their own NDA numbers[4][5]. Published Phase 3 efficacy for semaglutide 2.4 mg (~14.9% mean weight loss over 68 weeks) comes from the STEP 1 trial[6], and for tirzepatide (~20.9% at the 15 mg dose over 72 weeks) from SURMOUNT-1[7]; the SURMOUNT-5 head-to-head published in 2025 compared the two directly[8].
Insurance coverage for anti-obesity medications varies widely by state Medicaid program and commercial plan[9][10]. Compounded and brand-name GLP-1s are generally FSA/HSA eligible with a prescription under IRS Publication 502[11].
Frequently Asked Questions
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 5.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 8.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
- 9.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 10.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.
- 11.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.